MARLENE CERECERES: Open Payments
NPI 1649825001 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,230 in 44 payments from 15 companies in 2025. Trend: 2023 $435 · 2024 $612 · 2025 $1,230
Food & beverage: $1,230
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $283 |
| Abbott Laboratories | 3 | $225 |
| Astellas Pharma US Inc | 5 | $165 |
| ABBVIE INC. | 5 | $105 |
| PFIZER INC. | 4 | $83 |
| Paratek Pharmaceuticals, Inc. | 3 | $73 |
| Amgen Inc. | 4 | $72 |
| Lilly USA, LLC | 3 | $57 |
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
| Lundbeck LLC | 2 | $37 |
Products named: Wegovy, FREESTYLE LIBRE 3, Veozah, MOUNJARO, ELIQUIS, OTEZLA, UBRELVY, FREESTYLE LIBRE.
Industry payments across TX — which companies pay providers there.
